Bellerophon Therapeutics logo
Bellerophon Therapeutics BLPH
$ 0.1 -74.18%

Quarterly report 2023-Q3
added 11-14-2023

report update icon

Bellerophon Therapeutics Cash and Cash Equivalents 2011-2024 | BLPH

Annual Cash and Cash Equivalents Bellerophon Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.92 M 24.7 M 47.6 M 9.87 M 16.6 M 28.8 M 14.5 M 6.26 M 16.8 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
47.6 M 6.26 M 19.1 M

Quarterly Cash and Cash Equivalents Bellerophon Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
4.38 M 10.6 M 15.2 M 6.92 M 11.3 M 16.3 M 20 M 24.7 M 28.7 M 34.3 M 39.7 M 47.6 M 47.6 M 47.6 M 47.6 M 9.87 M 9.87 M 9.87 M 9.87 M 16.6 M 16.6 M 16.6 M 16.6 M 28.8 M 28.8 M 28.8 M 28.8 M 14.2 M 14.5 M 14.5 M 14.5 M 6.26 M 6.26 M 6.26 M 6.26 M 16.8 M 16.8 M 16.8 M 16.8 M - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
47.6 M 4.38 M 19.8 M